Opexa Therapeutics

Opexa Therapeutics is a commercialization driven biotechnology cellular therapy company that develops autologous personalized cell therapies for the treatment of various diseases. The Company is focused on its proprietary stem cell and T-cell technologies for the autologous use of peripheral blood derived adult stem cells in regenerative medicine as well as T cells for the treatment of autoimmune diseases amenable to T-cell based therapies. The Company is currently developing the strategies for the use of monocyte derived stem cells (MDSC) in pre-clinical safety and effectiveness studies for the treatment of congestive heart failure (CHF) and type 1 diabetes (T1D). Cardiac tissue regeneration using MDSCs and pancreatic beta cell-differentiated MDSCs in diabetes are targeted as the first stem cell indications. The Company is currently in Phase I/II clinical trials with its novel T-cell therapy Tovaxin™ for the treatment of multiple sclerosis.

Contact Details: 2635 N. Crescent Ridge Drive The Woodlands TX 77381 United States of America Tel: 281-272-9331 Fax: 281-272-1088 Email: ir@opexatherapeutics.com WWW: www.opexatherapeutics.com/

Loading...

Press Releases on Opexa Therapeutics:
Reportlinker Adds Global Stem Cell and Advanced Technologies Market	10th November, 2009	Reportlinker	-- Stem Cell Applications (regenerative medicine - neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases,
Reportlinker Adds Stem Cell Therapeutics Markets Report	24th September, 2009	Reportlinker	-- Cardiovascular disease -- Lung disease -- Arthritis -- Incontinence -- Osteoporosis -- Diabetes -- Cancer -- Orthopedics

BioNews Results for Opexa Therapeutics:
Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009	Pharma Live:  Nov 5 2009 7:38PM Matching: opexa therapeutics
Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009	Genetic Engineering News:  Nov 5 2009 2:59PM Matching: opexa therapeutics
Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009	Yahoo! Canada:  Nov 5 2009 6:21PM Matching: opexa therapeutics
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update	Individual.com:  Nov 4 2009 3:13PM Matching: opexa therapeutics
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update	Genetic Engineering News:  Nov 4 2009 3:25PM Matching: opexa therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Opexa Therapeutics news.

Opexa Therapeutics (OPXA) Financial information Links from Barchart
OPXA Quote from from Barchart.com
OPXA Chart from from Barchart.com
OPXA Profile from from Barchart.com
OPXA Opinion from from Barchart.com
→View more Opexa Therapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 310 times since April 2007, the link to the organisation's website has been followed 68 times

Search for more companies in The Woodlands

Search for more companies in TX

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Opexa Therapeutics